Moukheibir Catherine 4
4 · MoonLake Immunotherapeutics · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Moukheibir Catherine
Director
Transactions
- Award
Option to Buy
2023-06-08+11,297→ 11,297 totalExercise: $29.18Exp: 2033-06-08→ Class A ordinary shares, par value $0.0001 per share (11,297 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 11,297 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 8, 2024 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.